We are live on ! Find out more
JG

Jefferies Group Portfolio holdings

AUM $12B
1-Year Est. Return 6.2%
This Fund
S&P 500
This Quarter Est. Return
+28.1%
1 Year Est. Return
-6.2%
3 Year Est. Return
+88.85%
5 Year Est. Return
+123.14%
10 Year Est. Return
AUM
$8.49M
AUM Growth
-$9B
Cap. Flow
-$2.81B
Cap. Flow %
-33,155.67%
Top 10 Hldgs %
37.99%
Holding
2,297
New
319
Increased
303
Reduced
441
Closed
1,073

Sector Composition

Rank Sector Weight
1 Healthcare 3.74%
2 Technology 3.62%
3 Industrials 3.49%
4 Consumer Discretionary 3%
5 Communication Services 2.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBAY icon
126
eBay
EBAY
$48.4B
$10.4K 0.12%
198,000
+81,796
+70% +$3.46M
XPO icon
127
XPO
XPO
$25.3B
$10.3K 0.12%
383,960
-382,259
-50% -$9.15M
NVRO
128
CALL
DELISTED
NEVRO CORP.
NVRO
$10.2K 0.12%
+85,000
New +$10.1M
EIX icon
129
Edison International
EIX
$30.7B
$10.1K 0.12%
185,479
+4,766
+3% +$274K
OTIS icon
130
Otis Worldwide
OTIS
$27.5B
$10.1K 0.12%
+177,093
New +$9.18M
SGI
131
CALL
Somnigroup International
SGI
$15.2B
$10.1K 0.12%
+559,200
New +$8.02M
MRTX
132
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$9.92K 0.12%
86,913
-640
-0.7% -$62.1K
CVS icon
133
PUT
CVS Health
CVS
$137B
$9.88K 0.12%
152,000
-79,100
-34% -$4.98M
WPM icon
134
CALL
Wheaton Precious Metals
WPM
$51B
$9.85K 0.12%
223,600
-26,700
-11% -$1.05M
AMD icon
135
Advanced Micro Devices
AMD
$878B
$9.8K 0.12%
186,200
+175
+0.1% +$9.28K
EXAS
136
DELISTED
Exact Sciences
EXAS
$9.79K 0.12%
112,572
+105,711
+1,541% +$8.45M
CCL icon
137
CALL
Carnival Corporation Ltd
CCL
$36.4B
$9.77K 0.12%
595,000
+581,900
+4,442% +$8.72M
XYZ
138
Block Inc
XYZ
$46.4B
$9.7K 0.11%
92,432
+28,377
+44% +$2.17M
QCOM icon
139
PUT
Qualcomm
QCOM
$178B
$9.65K 0.11%
105,800
-20,400
-16% -$1.64M
CACC icon
140
CALL
Credit Acceptance
CACC
$6.09B
$9.64K 0.11%
+23,000
New +$8.01M
ILMN icon
141
Illumina
ILMN
$29.6B
$9.63K 0.11%
26,721
+23,332
+688% +$7.51M
MASI
142
CALL
DELISTED
Masimo
MASI
$9.58K 0.11%
+42,000
New +$9.22M
GBT
143
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
$9.56K 0.11%
151,500
+14,800
+11% +$1.02M
PPLI
144
CALL
People Inc
PPLI
$3.13B
$9.42K 0.11%
497,991
+495,753
+22,152% +$22M
CRM icon
145
Salesforce
CRM
$133B
$9.39K 0.11%
50,118
+44,099
+733% +$7.43M
DMLP icon
146
Dorchester Minerals
DMLP
$1.34B
$9.26K 0.11%
724,381
+144,584
+25% +$1.64M
NKLAW
147
DELISTED
Nikola Corporation Warrant expiring 6/3/2025
NKLAW
$9.21K 0.11%
+277,500
New +$7.92M
JNJ icon
148
CALL
Johnson & Johnson
JNJ
$634B
$9.14K 0.11%
65,000
-36,300
-36% -$5.29M
DIS icon
149
Walt Disney
DIS
$166B
$9.07K 0.11%
81,338
+75,932
+1,405% +$8.38M
ALNY icon
150
PUT
Alnylam Pharmaceuticals
ALNY
$36.5B
$8.89K 0.1%
60,000

Similar funds

Jefferies Group's Q2 2020 Portfolio in Review

As of Q2 2020, Jefferies Group held 2,297 positions worth $8.49M, down 100% from $9.01B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Jefferies Group withdrew a net $2.81B in Q2 2020, closing 1,073 positions and reducing 441 holdings. Its most notable exit was Allergan plc, an estimated $47.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.7% of assets, down from 3.9% a quarter earlier, followed by Technology and Industrials.

Against the trend, Jefferies Group opened a new position in Argo Group International Holdings, Ltd. worth $27.4K.

  • Jefferies Group's largest Q2 2020 buy was Argo Group International Holdings, Ltd.: 785,648 shares worth $27.4K.
  • Jefferies Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $300M increase.
  • Jefferies Group's biggest Q2 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $60.9M.
  • Jefferies Group fully exited Allergan plc in Q2 2020, selling an estimated $47.7M.
  • Jefferies Group's ten largest holdings make up 38% of its $8.49M portfolio in Q2 2020.
  • Jefferies Group opened 319 new positions and closed 1,073 in Q2 2020.
  • Jefferies Group's portfolio value fell 100% quarter-over-quarter to $8.49M.

Based on Jefferies Group's 13F filing for Q2 2020, filed 14 Aug 2020.